Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Melphalan × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 7 Multiple Myeloma 6 Hematologic Neoplasms 6 Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Neuroblastoma 4 Leukemia, Biphenotypic, Acute 4 Leukemia 4 Hematologic Diseases 4 Leukemia, B-Cell 3 Hodgkin Disease 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myeloproliferative Disorders 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2

Interventions

Dexamethasone 8 Lenalidomide 7 Bortezomib 5 pomalidomide 3 carfilzomib 3 Calcium Dobesilate 3 Prednisone 2 poly ICLC 1 ibrutinib 1 fludarabine 1 elotuzumab 1 daratumumab 1 citarinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Sirolimus 1 PVX-410 vaccine 1 Mycophenolic Acid 1 Melphalan 1 Granulocyte Colony-Stimulating Factor 1 Everolimus 1 Cyclophosphamide 1 Clonal Hematopoiesis 1 Chromatin Immunoprecipitation Sequencing 1 Blood Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01208766 2026-01-06

HO95

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡